Gordon Schanzlin New Vision Institute is a clinical research site located in La Jolla, California, United States 92307.
Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.
Gordon Schanzlin New Vision Institute has participated in 2 clinical trials.
Therapeutic areas: Presbyopia, Meibomian Gland Dysfunction, Dry Eye Syndromes.
Sponsors: Ocuphire Pharma, Inc., Novoxel Ltd..
Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Gordon Schanzlin New Vision Institute has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Gordon Schanzlin New Vision Institute has 2 clinical trials on record. Their work covers Presbyopia, Meibomian Gland Dysfunction, Dry Eye Syndromes.
Gordon Schanzlin New Vision Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.